97.38
price down icon0.94%   -0.92
after-market After Hours: 97.39 0.01 +0.01%
loading
Alcon Inc stock is traded at $97.38, with a volume of 1.26M. It is down -0.94% in the last 24 hours and up +16.18% over the past month. Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
See More
Previous Close:
$98.30
Open:
$98.49
24h Volume:
1.26M
Relative Volume:
0.77
Market Cap:
$47.15B
Revenue:
$9.91B
Net Income/Loss:
$1.02B
P/E Ratio:
47.50
EPS:
2.05
Net Cash Flow:
$665.00M
1W Performance:
+2.16%
1M Performance:
+16.18%
6M Performance:
+5.34%
1Y Performance:
+22.38%
1-Day Range:
Value
$97.33
$98.56
1-Week Range:
Value
$95.30
$99.20
52-Week Range:
Value
$79.63
$101.10

Alcon Inc Stock (ALC) Company Profile

Name
Name
Alcon Inc
Name
Phone
-
Name
Address
-
Name
Employee
25,599
Name
Twitter
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
ALC's Discussions on Twitter

Compare ALC with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Instruments & Supplies icon
ALC
Alcon Inc
97.38 47.15B 9.91B 1.02B 665.00M 2.05
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
531.82 184.23B 8.71B 2.48B 1.75B 6.82
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
167.00 58.65B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
RMD
Resmed Inc
240.66 35.34B 5.02B 1.31B 1.56B 8.91
Medical Instruments & Supplies icon
COO
The Cooper Companies, Inc.
81.57 16.25B 3.90B 392.30M 288.10M 1.95

Alcon Inc Stock (ALC) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-28-25 Reiterated Needham Buy
Mar-25-25 Upgrade BofA Securities Neutral → Buy
Jan-24-25 Reiterated Needham Buy
Jan-10-25 Upgrade Redburn Atlantic Neutral → Buy
Dec-17-24 Reiterated Needham Buy
Nov-12-24 Reiterated Needham Buy
Oct-10-24 Upgrade Redburn Atlantic Sell → Neutral
Sep-10-24 Upgrade RBC Capital Mkts Sector Perform → Outperform
Jul-15-24 Upgrade Morgan Stanley Underweight → Equal-Weight
May-15-24 Upgrade Oppenheimer Perform → Outperform
Apr-10-24 Initiated Goldman Buy
Mar-14-24 Initiated RBC Capital Mkts Sector Perform
Feb-06-24 Resumed KeyBanc Capital Markets Overweight
Jan-23-24 Initiated Bernstein Outperform
Dec-18-23 Downgrade Redburn Atlantic Neutral → Sell
Dec-12-23 Initiated Stifel Buy
Dec-04-23 Downgrade Morgan Stanley Equal-Weight → Underweight
Aug-17-23 Upgrade JP Morgan Neutral → Overweight
May-30-23 Resumed Morgan Stanley Equal-Weight
May-10-23 Upgrade Robert W. Baird Neutral → Outperform
Mar-01-23 Upgrade Societe Generale Sell → Hold
Dec-22-22 Initiated Mizuho Buy
Nov-17-22 Downgrade Societe Generale Hold → Sell
Aug-11-22 Downgrade Societe Generale Buy → Hold
May-13-22 Resumed Credit Suisse Outperform
May-12-22 Upgrade Stephens Equal-Weight → Overweight
Apr-08-22 Initiated Needham Buy
Mar-11-22 Initiated BofA Securities Buy
Jan-18-22 Downgrade Stephens Overweight → Equal-Weight
Jan-07-22 Downgrade Morgan Stanley Overweight → Equal-Weight
Oct-01-21 Initiated Oppenheimer Perform
Jul-14-21 Initiated Deutsche Bank Buy
May-06-21 Upgrade Citigroup Sell → Neutral
Mar-22-21 Upgrade BTIG Research Neutral → Buy
Nov-12-20 Downgrade Guggenheim Buy → Neutral
Jul-06-20 Downgrade Citigroup Neutral → Sell
Jul-06-20 Initiated KeyBanc Capital Markets Sector Weight
Jun-16-20 Upgrade Guggenheim Neutral → Buy
Apr-08-20 Downgrade Robert W. Baird Outperform → Neutral
Mar-26-20 Upgrade Argus Hold → Buy
Mar-24-20 Upgrade Societe Generale Sell → Hold
Mar-13-20 Upgrade UBS Neutral → Buy
Mar-05-20 Initiated Citigroup Neutral
Feb-26-20 Upgrade Berenberg Hold → Buy
Jan-08-20 Initiated Argus Hold
Oct-29-19 Initiated Stephens Equal-Weight
Aug-21-19 Reiterated BofA/Merrill Neutral
Jun-24-19 Initiated SVB Leerink Mkt Perform
Jun-14-19 Initiated BTIG Research Neutral
May-10-19 Initiated Robert W. Baird Outperform
May-02-19 Initiated Credit Suisse Outperform
View All

Alcon Inc Stock (ALC) Latest News

pulisher
02:05 AM

Institutional investors are Alcon Inc.'s (VTX:ALC) biggest bettors and were rewarded after last week's CHF1.2b market cap gain - simplywall.st

02:05 AM
pulisher
May 01, 2025

Do Options Traders Know Something About Alcon Stock We Don't? - TradingView

May 01, 2025
pulisher
Apr 28, 2025

RBC Bets On Alcon's Growth With Continued Outperform Rating - Finimize

Apr 28, 2025
pulisher
Apr 28, 2025

RBC Keeps Alcon at Outperform Ahead of Q1 Results - marketscreener.com

Apr 28, 2025
pulisher
Apr 26, 2025

Alcon (ALC) Gets a Buy from RBC Capital - The Globe and Mail

Apr 26, 2025
pulisher
Apr 25, 2025

Alcon Rolls Out Unity Vitreoretinal and Cataract Surgery Systems - Medical Product Outsourcing

Apr 25, 2025
pulisher
Apr 25, 2025

Alcon Elevates Vitreoretinal and Cataract Surgery for Superior E - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Alcon Elevates Vitreoretinal and Cataract Surgery for Superior Efficiency* with UNITY VCS and UNITY CS - marketscreener.com

Apr 25, 2025
pulisher
Apr 24, 2025

Corneal Topographers Market Deep Research 2025-2032 | Alcon plc., Abbott Laboratories, Topcon Corporation - openPR.com

Apr 24, 2025
pulisher
Apr 23, 2025

WCO & Alcon Dry Eye Wheel launches in French - childrennow.co.uk

Apr 23, 2025
pulisher
Apr 22, 2025

Village Roadshow’s $417.5 Million Stalking Horse Deal Approved - Bloomberg.com

Apr 22, 2025
pulisher
Apr 22, 2025

Alcon Entertainment Appoints Former MGM Exec Steven Johnson As EVP, Head Of Physical Production - IMDb

Apr 22, 2025
pulisher
Apr 20, 2025

Alcon lines up product launches in India, bets on rising demand for advanced eye care - MSN

Apr 20, 2025
pulisher
Apr 15, 2025

Lobbying Update: $150,000 of ALCON VISION LLC lobbying was just disclosed - Nasdaq

Apr 15, 2025
pulisher
Apr 15, 2025

Aniridia Treatment Market Is Going to Boom | Major Giants Alcon, Santen Pharmaceutical, Johnson & Johnson Vision - openPR.com

Apr 15, 2025
pulisher
Apr 15, 2025

There's Been No Shortage Of Growth Recently For Alcon's (VTX:ALC) Returns On Capital - Yahoo Finance

Apr 15, 2025
pulisher
Apr 10, 2025

Alcon: A Clear Vision, But Fully Valued (NYSE:ALC) - Seeking Alpha

Apr 10, 2025
pulisher
Apr 09, 2025

GE HealthCare Hires Alcon Exec Jeannette Bankes as Patient Care Solutions CEO - Medical Product Outsourcing

Apr 09, 2025
pulisher
Apr 09, 2025

High-level Milwaukee-area GE HealthCare exec to retire - The Business Journals

Apr 09, 2025
pulisher
Apr 08, 2025

Ophthalmic Devices Market Set to Attain Valuation of US$ 83.33 Billion By 2033 | Astute Analytica - GlobeNewswire Inc.

Apr 08, 2025
pulisher
Apr 08, 2025

Here’s Why ClearBridge Large Cap Growth Strategy Sold Alcon (ALC) - Insider Monkey

Apr 08, 2025
pulisher
Apr 08, 2025

Tesla, Warner Bros fend off some claims in 'Blade Runner 2049' ad dispute - Reuters

Apr 08, 2025
pulisher
Apr 08, 2025

Alcon (VTX:ALC) Seems To Use Debt Quite Sensibly - simplywall.st

Apr 08, 2025
pulisher
Apr 07, 2025

Alcon Scoops Up Aurion Biotech With Intent of Advancing Ophthalmology Cell Therapy AURN001 - CGTLive®

Apr 07, 2025
pulisher
Apr 05, 2025

US Tariffs Challenge Carl Zeiss Meditec And Smith & Nephew - Finimize

Apr 05, 2025
pulisher
Apr 05, 2025

Bernstein raises Alcon stock price target to CHF99 from CHF97.50 - Investing.com Canada

Apr 05, 2025
pulisher
Apr 04, 2025

Alcon, Aurion Reach Accord in Dispute Over Public Offering - Bloomberg Law News

Apr 04, 2025
pulisher
Apr 04, 2025

Bernstein raises Alcon stock price target to CHF99 from CHF97.50 By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 04, 2025

Dr. Jeffrey Martin of SightMD Becomes One of the First on Long Island to Implant the new Clareon® PanOptix® Pro Lens by Alcon - PRWeb

Apr 04, 2025
pulisher
Apr 04, 2025

Alcon Publishes Agenda for 2025 Annual General Meeting - Business Wire

Apr 04, 2025
pulisher
Apr 03, 2025

ALC Stock May Rise With the Introduction of PanOptix Pro in US - MSN

Apr 03, 2025
pulisher
Apr 02, 2025

Alcon Introduces Clareon PanOptix Pro Intraocular Lens - Medical Product Outsourcing

Apr 02, 2025
pulisher
Apr 02, 2025

Alcon Expands Leadership in IOL Innovation with Clareon PanOptix - GuruFocus

Apr 02, 2025
pulisher
Apr 02, 2025

Alcon Expands Leadership in IOL Innovation with Clareon PanOptix Pro, Delivering Best-in-Class Light Utilization and Less Light Scatter – Company AnnouncementFT.com - Financial Times

Apr 02, 2025
pulisher
Apr 02, 2025

Alcon Expands Leadership in IOL Innovation with Clareon PanOptix Pro, Delivering Best-in-Class Light Utilization and Less Light Scatter - Morningstar

Apr 02, 2025
pulisher
Apr 01, 2025

The Zacks Analyst Blog Highlights Alcon, Glaukos and Regeneron Pharmaceuticals - Yahoo Finance

Apr 01, 2025
pulisher
Apr 01, 2025

Dry Eye Disease Market Growth in Future Scope 2025-2032 | - openPR.com

Apr 01, 2025
pulisher
Mar 31, 2025

KeyBanc raises Alcon stock price target to $112 on growth outlook - Investing.com Canada

Mar 31, 2025
pulisher
Mar 31, 2025

KeyBanc raises Alcon stock price target to $112 on growth outlook By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

3 Stocks to Watch in the Evolving Cell-Based Ophthalmic Therapy Space - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Deutsche Bank lifts Alcon stock price target to CHF96 from CHF92 - Investing.com Canada

Mar 31, 2025
pulisher
Mar 31, 2025

Deutsche Bank lifts Alcon stock price target to CHF96 from CHF92 By Investing.com - Investing.com South Africa

Mar 31, 2025

Alcon Inc Stock (ALC) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
medical_instruments_supplies BDX
$167.00
price down icon 1.05%
medical_instruments_supplies RMD
$240.66
price up icon 0.30%
medical_instruments_supplies COO
$81.57
price down icon 0.89%
medical_instruments_supplies BAX
$30.43
price down icon 0.91%
medical_instruments_supplies WST
$210.98
price down icon 0.15%
Cap:     |  Volume (24h):